IDEAYA Biosciences
Diana Munoz, Ph.D., currently serves as the Director and Head of Pharmacology at IDEAYA Biosciences, where responsibilities include leading in vivo/ex vivo research for multiple oncology programs, such as PARG and WRN, along with co-leading project teams for successful candidate identification. Prior experience includes positions at Nurix Therapeutics, where involvement in immuno-oncology programs resulted in the implementation of in vivo toxicity studies, and Novartis Institutes for BioMedical Research, where a high complexity DNA barcode library was established for genetic screening. Diana's academic journey includes a Ph.D. and MSc from the University of Toronto, alongside a BSc from York University, focused on medical biophysics and biology, respectively. Throughout academic and professional experience, Diana has contributed to significant publications and developed innovative research strategies in cancer biology and pharmacology.
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California